The Complex and Diverse Genetic Architecture of Dilated Cardiomyopathy

Circ Res. 2021 May 14;128(10):1514-1532. doi: 10.1161/CIRCRESAHA.121.318157. Epub 2021 May 13.

Abstract

Our insight into the diverse and complex nature of dilated cardiomyopathy (DCM) genetic architecture continues to evolve rapidly. The foundations of DCM genetics rest on marked locus and allelic heterogeneity. While DCM exhibits a Mendelian, monogenic architecture in some families, preliminary data from our studies and others suggests that at least 20% to 30% of DCM may have an oligogenic basis, meaning that multiple rare variants from different, unlinked loci, determine the DCM phenotype. It is also likely that low-frequency and common genetic variation contribute to DCM complexity, but neither has been examined within a rare variant context. Other types of genetic variation are also likely relevant for DCM, along with gene-by-environment interaction, now established for alcohol- and chemotherapy-related DCM. Collectively, this suggests that the genetic architecture of DCM is broader in scope and more complex than previously understood. All of this elevates the impact of DCM genetics research, as greater insight into the causes of DCM can lead to interventions to mitigate or even prevent it and thus avoid the morbid and mortal scourge of human heart failure.

Keywords: cardiomyopathies; genetics; genomics; heart failure; humans.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Alleles*
  • Cardiomyopathy, Dilated / genetics*
  • Cardiomyopathy, Dilated / prevention & control
  • Cohort Studies
  • Connectin / chemistry
  • Cross-Sectional Studies
  • Gene-Environment Interaction
  • Genetic Loci*
  • Genetic Variation*
  • Humans
  • Models, Statistical
  • Phenotype
  • Sarcomeres / chemistry

Substances

  • Connectin
  • TTN protein, human